Olanzapine plus 17-β estradiol produce antidepressant-like actions in rats forced to swim

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 4, 2009, Pages 491-497

  Molina Hernández, Miguel ^a   Téllez Alcántara, N Patricia ^a   Olivera Lopez, Jorge I ^b,c   Jaramillo, M Teresa ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Allopregnanolone; Antidepressant; Estradiol; Olanzapine

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTRADIOL; FINASTERIDE; FLUOXETINE; OLANZAPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; LOCOMOTION; MOTOR PERFORMANCE; NONHUMAN; OPEN FIELD TEST; OVARIECTOMY; PRIORITY JOURNAL; PROGESTERONE METABOLISM; RAT;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ESTRADIOL; FEMALE; FLUOXETINE; MALE; MOTOR ACTIVITY; OVARIECTOMY; PREGNANOLONE; PROGESTERONE; RATS; SEROTONIN UPTAKE INHIBITORS; SWIMMING;

RATTUS;

EID: 67849134879     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.06.015     Document Type: Article

References (48)

1. Ahnaou A., Megens A., and Drinkenburg W. The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats. Neuropsychobiology 48 (2003) 47-54
2. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-160
3. Brotto L., Barr A., and Gorzalka B. Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. Eur J Pharmacol 402 (2000) 87-93
4. Cervo L., Grignaschi G., and Samanin R. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin-1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur J Pharmacol 158 (1988) 53-59
5. Contreras C.M., Molina M., Sabedra M., and Martínez L. Lateral septal neuronal firing rate increases during proestrus-estrus in the rat. Physiol Behav 68 (2000) 279-284
6. Crawley J.N. Exploratory behavior models of anxiety in mice. Neurosci Biobehav 9 (1985) 37-44
7. Davis L., Bartolucci A., and Petty F. Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affectiv Disord 85 (2005) 259-266
8. Delini-Stula A., Mikkelsen H., and Angst J. Therapeutic efficacy of antidepressants in agitated anxious depression - a metaanalysis of moclobemide studies. J Affect Disord 35 (1995) 21-30
9. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995) 66-72
10. Detke M.J., and Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73 (1996) 43-46
11. Dodd S., Horgan D., Malhi G., and Berk M. To combine or not to combine? A literature review of antidepressant combination therapy. J Affectiv Disord 89 (2005) 1-11
12. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 169-192
13. Eser D., Schüle C., Baghai T.C., Romeo E., Uzunov D.P., and Rupprecht R. Neuroactive steroids and affective disorders. Pharmacol Biochem Behav 84 (2006) 656-666
14. Eser D., Romeo E., Baghai T., Di Michele F., Schüle C., Pasini A., Zwanzger P., Padberg F., and Rupprecht R. Neuroactive steroids as modulators of depression and anxiety. Neuroscience 138 (2006) 1041-1048
15. Estrada E., Fernández-Guasti A., and López C. Participation of the 5HT-1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacol 31 (2006) 247-255
16. Finkel S. Pharmacology of antipsychotics in the elderly: a focus on atypicals. J Am Geriatr Soc 52 (2004) S258-S265
17. Frisone D.F., Frye C.A., and Zimmerberg B. Social isolation stress during the third week of life has age-dependent effects on spatial learning in rats. Behav Brain Res 128 (2002) 153-160
18. Frye C., and Walf A. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 41 (2002) 306-315
19. Frye C.A., and Rhodes M.E. Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone. Pharmacol Biochem Behav 81 (2005) 907-916
20. Gavioli E.C., Duarte F., Bressan E., Ferrara P., Coimbra R., and Monteiro De Lima T.C. Antidepressant-like effect of Ro5-4864, a peripheral-type benzodiazepine receptor ligand, in forced swimming test. Eur J Pharmacol 471 (2003) 21-26
21. Gutiérrez A., Contreras C.M., Mendoza R., García O., and Cruz J.S. Urine from stressed rats increases immobility in receptor rats forced to swim: role of 2-heptanone. Physiol Behav 91 (2007) 166-172
22. Harkin A., Kelly J.P., McNamara M., Connor T.J., Dredge K., Redmond A., and Leonard B.E. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol 364 (1999) 123-132
23. Klint T., and Weikop P. Monoamine transporters as continuing targets for drug discovery in depression. Drug Discov Today: Therapeutic Strategies 1 (2004) 111-116
24. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., and Rogawski M.A. Finasteride, a 5-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 288 (1999) 679-684
25. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neuroscience Biobehav Rev 25 (2001) 117-142
26. Lephart E.D., Ladle D.R., Jacobson N.A., and Rhees R.W. Inhibition of brain 5αreductase in pregnant rats: effects on enzymatic and behavioural activity. Brain Res 739 (1996) 356-360
27. Martínez L., Cruz J.J., Márquez S., and Fernández-Guasti A. Estrogens participate in the antidepressant-like effect of desipramine and fluoxetine in male rats. Pharmacol Biochem Behavior 88 (2008) 332-340
28. Marx C., Shampine L., Khisti R., Trost W., Bradford D., Grobin A., Massing M., Madison R., Butterfield M., Lieberman J., and Morrow L. Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnenolone and peripheral deoxycorticosterone: implications for therapeutic actions. Pharmacol Biochem Behav 84 (2006) 609-617
29. Molina M., Perez J., and Olivera J.I. Female Wistar rats tested during late proestrus or during pregnancy and ovariectomized rats tested after receiving progesterone or allopregnanolone displayed reduced conflict behavior. Prog in Neuro-Psychopharmacol Biol Psychiatry 26 (2002) 839-844
30. Molina-Hernández M., Téllez-Alcántara N.P., Pérez-García J., Olivera-Lopez J.I., and Jaramillo T. Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats. Pharmacol Biochem Behav 80 (2005) 401-409
31. Molina M., Tellez-Alcántara N.P., Pérez-García J., Olivera-Lopez J.I., and Jaramillo-Jaimes M.T. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 380-386
32. National Institutes of Health. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
33. Nemeroff C.B. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatric Res 41 (2007) 189-206
34. Okada M., Hayashi N., Kometani M., Nakao K., and Inukai T. Influences of ovariectomy and continuous replacement of 17 beta estradiol on the tail skin temperature and behavior in the forced swimming test in rats. Jpn J Pharmacol 73 (1997) 93-96
35. Payne V.M., Kilts J.D., Naylor J.C., Strauss J.L., Calhoun P.S., Madison R.D., and Marx C.E. Allopregnanolone and pregnenolone alterations following pharmacological agents in rodents and clinical populations. In: Risner M.S., and Weizman A. (Eds). Neuroactive steroids in brain function, behavior and neuropsychiatric disorders (2008) 369-383 U.S.A
36. Pinna G., Costa E., and Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology 186 (2006) 362-372
37. Porsolt R.D., LePichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
38. Seddon K., and Nutt D. Pharmacological treatment of bipolar disorder. Psychiatry 6 (2007) 305-308
39. Seeman M.V., and Ross L.E. Sex steroids, response to stress and susceptibility to depression. In: Fink G. (Ed). Encyclopedia of stress. Second Edition (2007), Elsevier Inc. 474-479
40. Shelton R., and Papakostas G. Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Acta Psychiatr Scand 117 (2008) 253-259
41. Sloan D., and Kornstein S. Gender differences in depression and response to antidepressant treatment. Psychiatric Clinics of North America 26 (2003) 581-594
42. Treit D., and Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31 (1988) 959-962
43. Uzunov D.P., Cooper T.B., Costa E., and Guidotti A. Fluoxetine elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA 93 (1996) 12599-12604
44. Uzunova V., Wrynn A.S., Kinnunen A., Ceci M., Kohler C., and Uzunov D.P. Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. Eur J Pharmacol 486 (2004) 31-34
45. Vieta E. Mood stabilization in the treatment of bipolar disorder: focus on quetiapine. Hum Psychopharmacol 20 (2005) 225-236
46. Walf A., and Frye C.A. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 30 (2005) 1288-1301
47. Walf A., and Frye C.A. Parity and estrogen-administration alter affective behavior of ovariectomized rats. Physiol Behav 93 (2008) 351-356
48. Westlund L., and Parry B. Does estrogen enhance the antidepressant effects of fluoxetine?. J Affect Disord 77 (2003) 87-92